V good summation Von I too would add that any major looking at pericoach's sales re a distribution deal would hope to see encouraging stats re sales over last 2 qtrs from alt's efforts
thats what i would of hoped to be 1/ potential to be seen re: better that expected sales 2/ strong clinical trialling from v happy end users Now all we got to go on will be the trials and lets face it Will this be enough for a biggie to take the risk and stock up on ALT ?
Strategic Review - Urgently Required, page-17
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
